ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $341,000 | -53.4% | 7,378 | -75.5% | 0.02% | -58.6% |
| Q1 2019 | $732,000 | +2340.0% | 30,069 | +1333.9% | 0.06% | +1833.3% |
| Q4 2018 | $30,000 | +650.0% | 2,097 | +635.8% | 0.00% | – |
| Q3 2018 | $4,000 | -100.0% | 285 | -73.2% | 0.00% | -100.0% |
| Q2 2018 | $17,854,000 | +148683.3% | 1,064 | +44.4% | 0.00% | +100.0% |
| Q1 2018 | $12,000 | -33.3% | 737 | -65.4% | 0.00% | -50.0% |
| Q2 2017 | $18,000 | -5.3% | 2,129 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $19,000 | +375.0% | 2,121 | +357.1% | 0.00% | – |
| Q4 2016 | $4,000 | – | 464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |